"Midkine-based drugs mayblock:..."
That word "may" makes Midkine sound like a lottery ticket.
All the narrative, photo's and supporting data suggest a feeling of "certainty" of sickness, but the Midkine silver bullet is not given the same level of certainty.
Given they are only looking for 3 million quid, nobody can argue the presentation is a cheap skate one. Quite the opposite in fact.
Ann: Agreement Signed for Sale of Lyramid Limited, page-297
Add AN1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| AN1 (ASX) Chart |
Day chart unavailable